OMERS Administration Corp’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.33M Buy
19,291
+4,985
+35% +$1.24M 0.03% 282
2025
Q4
$3.45M Buy
14,306
+1,586
+12% +$406K 0.02% 249
2025
Q3
$3.48M Sell
12,720
-700
-5% -$191K 0.02% 245
2025
Q2
$3.46M Sell
13,420
-300
-2% -$71.6K 0.03% 217
2025
Q1
$3.07M Buy
13,720
+1,849
+16% +$432K 0.03% 243
2024
Q4
$2.71M Sell
11,871
-2,518
-17% -$606K 0.02% 257
2024
Q3
$3.51M Hold
14,389
0.03% 219
2024
Q2
$2.75M Buy
+14,389
New +$2.92M 0.03% 280
2018
Q1
Sell
-41,900
Closed -$3.55M 495
2017
Q4
$3.55M Buy
+41,900
New +$3.46M 0.04% 193
2016
Q4
Sell
-48,800
Closed -$3.16M 503
2016
Q3
$3.16M Sell
48,800
-1,800
-4% -$120K 0.06% 191
2016
Q2
$3.2M Buy
50,600
+38,000
+302% +$2.24M 0.07% 179
2016
Q1
$729K Buy
+12,600
New +$713K 0.02% 348
2015
Q3
Sell
-5,300
Closed -$299K 471
2015
Q2
$299K Buy
+5,300
New +$335K 0.01% 381

Other funds holding RMD

OMERS Administration Corp's RMD Position: Q1 2026 in Review

OMERS Administration Corp increased its ResMed (RMD) stake by 35% in Q1 2026, buying an estimated $1.24M and bringing the position to 19,291 shares worth $4.33M. The position accounts for 0.03% of the portfolio, ranked #282.

OMERS Administration Corp first reported a position in RMD in Q2 2015 and has held it in 13 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • OMERS Administration Corp held 19,291 shares of ResMed worth $4.33M as of Q1 2026.
  • OMERS Administration Corp bought 4,985 ResMed shares in Q1 2026, an estimated $1.24M.
  • ResMed made up 0.03% of OMERS Administration Corp's portfolio in Q1 2026, its #282 holding.
  • OMERS Administration Corp first reported a position in ResMed in Q2 2015 and has held it in 13 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.